Elanco Animal Health (ELAN) Net Margin Growth (3y) (2020 - 2026)

Elanco Animal Health (ELAN) Net Margin Growth (3y) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1,620.00
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -98.00
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -4,358.00
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1,235.00
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -100.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 4,252.00
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -404.00
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 2,318.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -404.00
Dec 31, 2025 -1,864.00
Sep 30, 2025 334.00
Jun 30, 2025 174.00
Mar 31, 2025 146.00
Dec 31, 2024 866.00
Sep 30, 2024 4,489.00
Jun 30, 2024 1,190.00
Mar 31, 2024 780.00
Dec 31, 2023 1,470.00
Sep 30, 2023 -8,745.00
Jun 30, 2023 -13.00
Mar 31, 2023 1,564.00
Dec 31, 2022 -428.00
Sep 30, 2022 -763.00
Jun 30, 2022 -544.00
Mar 31, 2022 -15.00
Dec 31, 2021 -1,149.00
Sep 30, 2021 -1,746.00
Jun 30, 2021 -797.00